| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.3B | $7.1B | $6.5B | $6.5B | $7.7B | $1.7B | $1.5B | $1.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.2B | $2.3B | $2.0B | $2.4B | $3.7B | $2.7B | $2.4B | $2.4B |
| Net Income | $2.1B | $2.1B | $1.8B | $1.6B | $3.1B | $0.8B | $0.5B | $0.4B |
| EPS (Basic) | $9.26 | $9.18 | $7.78 | $6.73 | $13.25 | $3.36 | $2.27 | $1.43 |
| EPS (Diluted) | $9.24 | $9.15 | $7.76 | $6.70 | $13.12 | $3.33 | $2.24 | $1.41 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.3B | $13.5B | $12.3B | $11.6B | $12.5B | $10.7B | $9.3B | $7.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $3.4B | $2.6B | $2.1B | $1.8B | $1.5B | $2.2B | $1.8B | $1.4B |
| Total Liabilities | $2.3B | $2.0B | $2.0B | $2.0B | $2.3B | $1.4B | $1.1B | $0.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $10.9B | $10.3B | $9.5B | $8.8B | $9.0B | $7.7B | $7.1B | $6.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $1.7B | $1.2B | $2.4B | $3.5B | $1.9B | $1.5B | $1.6B |
| Investing Cash Flow | $0.2B | $-0.2B | $0.1B | $-0.0B | $-1.1B | $-0.0B | $-0.3B | $-0.9B |
| Capital Expenditures | $0.3B | $0.4B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $-1.3B | $-0.9B | $-1.1B | $-2.1B | $-3.0B | $-1.5B | $-0.8B | $-1.2B |